FDA — authorised 28 October 1953
- Status: approved
🇺🇸 Sulfurine in United States
FDA authorised Sulfurine on 28 October 1953
Marketing authorisations
FDA — authorised 28 October 1953
- Application: NDA008565
- Marketing authorisation holder: WYETH AYERST
- Local brand name: THIOSULFIL
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA080273
- Marketing authorisation holder: FOREST PHARMS
- Local brand name: PROKLAR
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA086012
- Marketing authorisation holder: FOREST PHARMS
- Local brand name: MICROSUL
- Indication: TABLET — ORAL
- Status: approved
Sulfurine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Sulfurine approved in United States?
Yes. FDA authorised it on 28 October 1953; FDA authorised it on 28 October 1953; FDA has authorised it.
Who is the marketing authorisation holder for Sulfurine in United States?
Marketing authorisation holder not available in our data.